| Elisabet de los Pinos, Ph.D. | President, Chief Executive Officer and Director | FY2025 | |
| Anthony Gibney | Chief Financial and Business Officer | FY2025 | |
| J. Jill Hopkins, M.D. | Chief Medical Officer and President of Research and Development | FY2025 |
3 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.